| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/16/2004 | US20040180809 Low molecular weight, hydrophilic Indole fluorescent dyes for assessing renal, hepatic, cardiac and organ functions; simple, safe, accurate, continuous monitoring |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180004 Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof |
| 09/16/2004 | US20040180003 comprises assessing changes in gene expression levels, levels of nucleic acids, proteins, or protein activity levels and determining whether the compound mimics effects induced by the CR diet program. |
| 09/16/2004 | CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 09/16/2004 | CA2516519A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/15/2004 | EP1457499A1 Inhibitors of extracellular Hsp90 |
| 09/15/2004 | EP1456664A1 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1455772A1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 09/15/2004 | EP1418808A4 Imaging marker transgenes |
| 09/15/2004 | EP1305317B1 Dihydroporphyrin derivatives and their uses |
| 09/15/2004 | EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 09/15/2004 | EP0979104B1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 09/15/2004 | CN1529594A Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 09/15/2004 | CN1529551A Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 09/15/2004 | CN1166677C Thiophene A2A receptor aganoists |
| 09/14/2004 | US6790621 Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a mdr1-encoding sequence |
| 09/10/2004 | WO2004077055A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/10/2004 | WO2004075925A1 Contrast medium for mri |
| 09/10/2004 | WO2004043357A3 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 09/10/2004 | WO2004042360A3 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| 09/10/2004 | CA2516579A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/09/2004 | US20040176684 Endoscope pretest capsule |
| 09/09/2004 | US20040176467 treating a non-psychotic human subject to prevent the development of psychotic symptoms; administering a selective D3 antagonist in an amount and dosage regimen sufficient to suppress psychotic symptoms in at risk patient |
| 09/09/2004 | US20040176378 for the treatment or prevention of ischemic-mediated central nervous system damage, including ischemic stroke |
| 09/09/2004 | US20040176326 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/09/2004 | US20040175329 Method for continuous visualization of a body lumen |
| 09/09/2004 | US20040175328 free-flowing, smooth, spherical microparticles of water-soluble material, mass median particle size of 1 to 10 mu m; inhalants |
| 09/09/2004 | DE19816370B4 Substituierte Mangan-D02A-Komplexe, diese enthaltende diagnostische Mittel und ihre Verwendung D02A-substituted manganese complexes, diagnostic agents containing them and their use |
| 09/08/2004 | EP1454137A2 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1347731A4 In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527066A 磁共振研究方法 Magnetic Resonance Research Methods |
| 09/08/2004 | CN1165272C Antimicrobial caries detecting composition |
| 09/07/2004 | US6787672 1-(4-methoxyphenyl)-3-(3,5-dimethoxyphenyl)prop-1-en-3-one derivatives; antiproliferative and antiinflammatory agents |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/02/2004 | WO2004075032A2 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| 09/02/2004 | WO2004074267A1 Trimeric macrocyclically substituted benzene derivatives |
| 09/02/2004 | WO2004073750A1 Improvements in or relating to contrast agents |
| 09/02/2004 | WO2004073656A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004041070A3 Mri probes of membrane potential |
| 09/02/2004 | WO2004026249A3 Methods and compositions for preventing skin damage |
| 09/02/2004 | WO2004005464A3 Compounds promoting delivery of genes |
| 09/02/2004 | WO2003063910A3 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 09/02/2004 | US20040171980 Method and apparatus for enhancement of transdermal transport |
| 09/02/2004 | US20040171928 Method |
| 09/02/2004 | US20040171534 chimeric analogs include a hydrophobic moiety (tail), and can be prepared, either by anchoring one or several hydrophobic tails to the GRF, or by substituting one or several amino-acids by a pseudomicellar residue in the chemical synthesis of GRF |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040170568 Stabilized preparations for use in metered dose inhalers |
| 09/02/2004 | US20040170566 Complex of metal compound and ligand; scavengers; magnetic resonance imaging; medical diagnosis |
| 09/02/2004 | US20040170565 Novel ultrasound contrast agents |
| 09/02/2004 | US20040170564 Ultrasound contrast agent dispersions comprising gas and destabilising agent |
| 09/02/2004 | US20040170563 Contrast agent; concurrent detection, activation; chelate compound and paramagnetic compound; anticancer agents |
| 09/02/2004 | US20040170562 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging |
| 09/02/2004 | US20040170560 Liposome confining prodrug, radioactive materials; multilayer; storage stability; antiinflammatory agents; infection therapy; antitumor agents imaging for diagnosis |
| 09/02/2004 | CA2516497A1 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| 09/02/2004 | CA2516467A1 Trimeric macrocyclically substituted benzene derivatives |
| 09/02/2004 | CA2516282A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/01/2004 | EP1451572A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 09/01/2004 | EP1450864A2 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 09/01/2004 | EP1450863A1 Methods for vascular imaging using nanoparticulate contrast agents |
| 09/01/2004 | EP1450859A2 Methods and compositions for the diagnosis of asthma |
| 09/01/2004 | EP1450751A2 Nanoparticle delivery vehicle |
| 09/01/2004 | CN1164335C Memory alloy capillary blood vessel suppository |
| 08/31/2004 | USRE38575 Diagnostic method for diabetes using C-13 labeled pyruvic acid |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/31/2004 | US6783752 Ultrasonic visualisation of perfusion in myocardium and other tissues is performed using novel gas-containing contrast agents which promote controllable and temporary growth of gas phase in vivo and therefore act as deposited perfusion tracers |
| 08/31/2004 | US6783751 Method for labeling biopolymers using isotopes |
| 08/26/2004 | WO2004071536A1 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 08/26/2004 | WO2004071535A1 Contrast enhanced x-ray phase imaging |
| 08/26/2004 | WO2004054623B1 Magnetic resonance imaging method and compounds for use in the method |
| 08/26/2004 | WO2004037314A3 Patch and kit containing delayed-type hypersensitivity inducer |
| 08/26/2004 | WO2004026111B1 Flexible and/or elastic brachytherapy seed or strand |
| 08/26/2004 | WO2004017922B1 Keto cannabinoids with therapeutic indications |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167330 Suitable targeting moieties are monoclonal antibodies, their fragments and recombinant derivatives such as single chain antibodies, diabodies, triabodies, humanized, human or chimeric variants but also peptides, aptamers, spiegelmers, nucleotides, anti sense oligomers |
| 08/26/2004 | US20040167102 Anticancer agents |
| 08/26/2004 | US20040167061 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 08/26/2004 | US20040166532 Administering labeled conjugated isoprenoids, lipids, saccharides, polyols or polyethylene glycols to mammals and monitoring presence in bodily fluids; forensic detection of coded compounds in mammals; drug abuse and dependence; drug screening |
| 08/26/2004 | US20040166152 Use of buckysome or carbon nanotube for drug delivery |
| 08/26/2004 | US20040166063 Pharmaceutical identification |
| 08/26/2004 | US20040166062 direct visualization of the distribution of therapeutic agents in animal tissue, utilizing chemical shift magnetic resonance imaging (MRI). chemical ablation procedures provide optimal dosage to target tumors while limiting effects on nearby tissue |
| 08/26/2004 | US20040166058 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/26/2004 | US20040163747 Nonskid device for the wheels of vehicles |
| 08/26/2004 | DE202004008616U1 Composition used in electroencephalography contains powdered lapis pumicis in connection with a conductive recipe |
| 08/26/2004 | CA2516409A1 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449541A1 Compositions inhibiting rejection in organ transplantation and method of using the same |
| 08/25/2004 | EP1448780A2 Direct targeting binding proteins |
| 08/25/2004 | EP1448194A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 08/25/2004 | EP1448191A1 Ilk inhibitors for the treatment of renal disease |
| 08/25/2004 | EP1448101A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| 08/25/2004 | EP0810853B1 Aerosols containing nanoparticle dispersions |
| 08/24/2004 | US6781029 Transgenic mouse for use as model in diagnosis and treatment of nervous and brain disorders |
| 08/24/2004 | US6780415 Animal model for infection by an apicomplexan parasite |
| 08/24/2004 | US6780397 6,8-bis(phosphinopropylthio)octanoic acid chemical intermediate; cancer and tumor diagnosis; radiopharmaceuticals |
| 08/19/2004 | WO2004069285A1 Improved radiometal complex compositions |